Genetic tests to assess the risk of breast and ovarian cancer can be performed remotely in the safety of the patients’ homes, according to data from an early Phase 1 trial. The trial findings also showed that genetic counseling sessions performed before and after testing can be skipped entirely without causing additional distress to patients. Data from the study was included in an oral presentation titled “Results from MAGENTA: A national randomized four-arm noninferiority trial…
You must be logged in to read/download the full post.
The post Genetic Testing for Breast, Ovarian Cancer Risk Safely Done at Home appeared first on BioNewsFeeds.